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Abstract
Introduction: International investment in the response to HIV and AIDS has plateaued and its future level is uncertain. With
many countries committed to ending the epidemic, it is essential to allocate available resources efficiently over different
response periods to maximize impact. The objective of this study is to propose a technique to determine the optimal allocation
of funds over time across a set of HIV programmes to achieve desirable health outcomes.
Methods: We developed a technique to determine the optimal time-varying allocation of funds (1) when the future annual HIV
budget is pre-defined and (2) when the total budget over a period is pre-defined, but the year-on-year budget is to be optimally
determined. We use this methodology with Optima, an HIV transmission model that uses non-linear relationships between
programme spending and associated programmatic outcomes to quantify the expected epidemiological impact of spending. We
apply these methods to data collected from Zambia to determine the optimal distribution of resources to fund the right
programmes, for the right people, at the right time.
Results and discussion: Considering realistic implementation and ethical constraints, we estimate that the optimal time-varying
redistribution of the 2014 Zambian HIV budget between 2015 and 2025 will lead to a 7.6% (7.3% to 7.8%) decrease in
cumulative new HIV infections compared with a baseline scenario where programme allocations remain at 2014 levels. This
compares to a 5.1% (4.6% to 5.6%) reduction in new infections using an optimal allocation with constant programme spending
that recommends unrealistic programmatic changes. Contrasting priorities for programme funding arise when assessing
outcomes for a five-year funding period over 5-, 10- and 20-year time horizons.
Conclusions: Countries increasingly face the need to do more with the resources available. The methodology presented here can
aid decision-makers in planning as to when to expand or contract programmes and to which coverage levels to maximize impact.
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Introduction
Despite ambitious targets to end the HIV epidemic, interna-
tional investment in the global HIV response has plateaued in
recent years [1,2]. At the same time, countries are increasingly
expected to fund HIV programmes domestically [3,4]. In this
context, it is imperative that countries achieve more with
available resources by allocating funds as efficiently as
possible. Allocative efficiency is the term used to describe
the allocation of funding across prevention, treatment, sup-
port and other programmes to achieve the greatest possible
impact in terms of specific objectives, such as reducing new
HIV infections or HIV-related deaths [5]. Allocative efficiency
can be quantitatively analyzed viamathematical and economic
modelling, using data on epidemiology, programme expendi-
ture and intervention effectiveness (under setting-specific
political and implementation constraints). Such analyses can
estimate the combination of programmes likely to have
greatest impact against defined health objectives and in turn
inform resource allocation planning [6,7].
Prioritizing HIV investments towards the most cost-effective
programmes (e.g. targeting key affected populations in
concentrated epidemics) can lead to substantial epidemiolo-
gical and economic improvements compared with historical
investment approaches [811]. Other studies have recently
highlighted the importance of geographical prioritization of
funds [12]. These modelling studies have generally assumed
investments or programme implementation strategies over
the analysis period that are constant over time, which may
not correspond to the optimal allocation in a given year.
Furthermore, these studies have tended to assume changes
in funding are instantaneous, whereas in the real world,
increases or decreases in funding are necessarily gradual.
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For example, if an optimized allocation implies doubling of
coverage of antiretroviral therapy (ART), this change is likely
to occur over several years.
The aim of this study is to advance allocative efficiency
methodologies by presenting an approach to calculate the
optimal allocation of resources over time across HIV pro-
grammes. Our methodology builds upon the previously
published Optima model [9]. Optima is a deterministic,
population-level HIV-transmission model that has provided
allocative efficiency results for over 30 countries [13]. Optima
uses non-linear relationships between programme funding
and programme outcome indicators to account for initial
programme implementation, programme scale-up, economies
of scale, and saturation of programme coverage. An optimiza-
tion algorithm, incorporating pre-defined conditions and
constraints, uses these relationships within the epidemic
model to determine the optimal distribution of funding across
a series of HIV programmes to best meet target objectives.
Here, we extend the optimization algorithm to allow alloca-
tions to the set of HIV programmes to vary over time within a
given total multi-year budget.
Our study aims to assess time-varying optimal resource
allocations for both fixed and variable annual budgets and also
for various time horizons to assess outcomes. To illustrate the
potential real-world benefits of time-varying optimal alloca-
tions, we applied our methodology to the HIV epidemic and
funding response in Zambia. The HIV epidemic in Zambia is
classified as generalized with overall adult prevalence esti-
mated at 13.5% [14]. The primary mode of HIV transmission
being heterosexual sex [15]. There has been substantial
investment in the Zambian HIV response, with an estimated
national HIV expenditure of US$208 million in 2006, rising
to US$411 million in 2014 [15,16], coinciding with a 40%
reduction in annual new infections between 2005 and 2013
[1]. The vast majority of total national HIV expenditure came
from external sources (estimated at 93% in 2012 with PEPFAR
and the Global Fund providing the most investment) with the
remaining investments from the government and the private
sector [15]. Previously, Optima was used to determine an
optimal resource allocation for Zambia that was constant over
time [15]. Here, we expand the previous analysis using our
time-varying allocation methodology.
Methods
Our methodology can be applied to any HIV-transmission
model that incorporates relationships between HIV pro-
gramme spending and associated risk behaviours or health
outcomes. Here, we use the Optima HIVmodel [9], which uses
demographic, behavioural, epidemiological, programmatic
and cost data to inform (1) cost-outcome curves that relate
programme spending to changes in behavioural and clinical
model parameters and (2) a transmission model that is then
used to project the impact of changes in programme spending
on the HIV epidemic. Optima has previously been used to
model the Zambian HIV epidemic [15].We use the data, model
calibration (Supplementary Figures 1 and 2) and cost-outcome
curves (Supplementary Figure 3) from this work for our case
study.
For spending to be ‘‘optimal,’’ the objectives of the funding
need to be defined. Typical objectives of investments in an
HIV context are to achieve epidemiological outcomes such
as reduced new HIV infections and/or AIDS-related deaths.
The optimization period must also be defined. Through the
choice of these objectives, an objective function is formed,
which can be calculated for any given allocation using
relationships between programme spending and outcomes
in their targeted populations and the associated projections
from the epidemiological model. The optimization algorithm
then navigates through the space of possible funding alloca-
tions to locate the allocation that minimizes the objective
function. The optimization algorithm is run until a minimum is
located or further improvements in health outcomes are
below a specified threshold (e.g. a 50% reduction in new HIV
infections relative to 2014 levels). This process is repeated
multiple times using a Monte Carlo initialization to increase
the liklihood of locating the global minimum. To perform the
optimization, we employ a Bayesian adaptive locally linear
stochastic descent algorithm [17].
In allocations that are constant over time, the optimization
algorithm works as follows. The allocation to each pro-
gramme is treated as a parameter in a vector of length n,
where n is the total number of programmes to be optimized.
These parameters are constrained such that they must be
non-negative and that the sum of all programme allocations
is equal to the total budget available at each time point. The
optimization algorithm then determines the optimal alloca-
tion of spending by evaluating model outputs that result
from different possible parameter vectors (i.e. programme
allocations). Instead of using a single parameter to represent
the funding available to each programme, as described
above, the time-varying method uses four parameters. We
use a function of the form
aðtÞ ¼ h  be
dt
ðh  bÞ  eg t þ b
to describe how funding to programmes can vary over time.
Here, the vectors of initial allocations b(b1. . .bn), the
growth rates g(g1. . .gn), the growth thresholds h
(h1. . .hn) and the decay rates d(d1. . .dn) are to be optimally
determined such that the objective function associated with
the allocation a(t)=(a1(t) . . . an(t)) is minimized. Here,
t(t1. . .tk) represents the optimization period of k time
points, which is mapped onto the closed (normalized)
interval [0, 1] and then translated to the actual period of
optimization (e.g. the operational budget over the period of a
national strategic plan). The initial allocation parameters, b,
can range between 0 and the total annual budget available in
the first time point of the optimization period, whilst the
threshold parameters, h, and the growth and decay rate
parameters, g and d, can take any real values. We illustrate
the effect of each of the parameter values in the Supple-
mentary file (Supplementary Figure 5). This function allows
allocations to be held constant (Supplementary Figure 6a),
‘‘front-loaded’’ or ‘‘rear-loaded’’ (Supplementary Figure 6b)
or initially scaled up/down and then later scaled down/up
(Supplementary Figure 6c).
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The allocation vector, a(t), that arises from the values of
the parameter vectors, b, g, h and d, is normalized such that
either of the following occurs:
1) Total programme spending, T(ti), equals a pre-defined
budget at each time point, ti. The pre-defined budget
can be either constant over the optimization period,
linearly decreasing or increasing or a step function of
likely future annual budgets.
2) Total programme spending across the whole optimiza-
tion period,
Pk
i¼1 TðtiÞ, is equal to a pre-defined
amount, but the total spending at each time point,
T(ti), is optimally determined. This is achieved by
defining a cubic polynomial for total programme
spending over time
TðtÞ ¼ c3t3 þ c2t2 þ c1t þ c0;
where c0 is equal to the sum of initial allocation
parameters b1. . .bn, and coefficients c1, c2 and c3 are
optimally determined such that (1) the objective
function associated with the allocation a(t) is minimized
and (2) the area under the polynomial is equal to the
pre-defined amount of funding available over the
optimization period.
Eight direct HIV prevention and treatment programmes
were considered in the time-varying optimization process:
ART; HIV testing and counselling (HTC); prevention of mother-
to-child transmission (PMTCT); voluntary medical male cir-
cumcision (VMMC) for adolescent and adult men; condom
programmes for men who have sex with men (MSM) and
female sex workers (FSW); and prevention programmes for
youth and general adults. The estimated national budget for
these programmes in 2014 was US$240 million (of the US$411
million total HIV budget).The primary sources of data were the
National AIDS Spending Assessment reports, Demographic
Health Surveys, UNGASS reports, the 2009 Zambia Sexual
Behavior Survey [1822] and Spectrum and Modes of
Transmission input files provided by in-country partners.These
data sources are described in detail elsewhere [15].
There are many aspects of planning future funding
allocations requiring the consideration of time. First, the
expected funding available for all programmes may change
over time (e.g. currently many countries are expecting a
decline in funding). Second, the achievement of strategic
outcomes may be desired in the short, medium or long term.
Third, knowing when to feasibly scale programmes up or
down is important for implementation purposes. To explore
these different aspects, we considered a number of optimi-
zation scenarios. For each of these scenarios, we determined
the optimal allocation of HIV funding to minimize the
cumulative number of new HIV infections using the described
time-varying optimization methodology:
1) The optimal allocation between 2015 and 2025 assum-
ing that the 2014 budget is annually available with no
predetermined constraints on the amount of funding
that could be allocated to each programme.
2) The optimal allocation between 2015 and 2025 assum-
ing that the 2014 budget is annually available with
‘‘implementation constraints’’ where funding to a
programme cannot increase or decrease beyond a given
proportion per year (we use 30% here) and ‘‘ethical
constraints’’ such that anyone who commences either
ART or PMTCT cannot cease receiving treatment except
by natural attrition.
3) The optimal allocation between 2015 and 2025 where
the total spending across the optimization period is
equal to that in scenarios 1 and 2, but total annual
spending is optimally determined within the restrictions
of the implementation and ethical constraints.
4) The optimal allocation of funding over five years but
where the cumulative number of new infections is
assessed after 5-, 10- and 20-year periods, again with
implementation and ethical constraints. Following the
period of optimally allocating resources, we assume
programmes continue at their levels of coverage
attained at the end of the optimization period. Such a
scenario may be of particular interest to decision-
makers who may only have a short term to impact
future health outcomes.
The implementation and ethical constraints in each of the
relevant scenarios take effect from the start of 2015. As such,
the optimal spending patterns in these scenarios are
dependent upon the existing programme allocations. To
generate a range of plausible solutions that consider model
uncertainty, we repeated the optimization process 40 times
by sampling from an ensemble of baseline projections within
the uncertainty bounds of the model calibration together
with an ensemble of cost-outcome curves within their
respective uncertainty bounds. To increase the likelihood of
the true optimal allocation being determined, we simulated
each scenario a further 40 times. The allocation associated
with the greatest epidemiological benefit was then selected
as the optimal solution.
Results and discussion
Our model of the Zambian HIV epidemic projects an estimated
559,100 (534,800 to 595,000) new HIV infections over 2015 to
2025 if 2014 budget levels and funding allocations across
programmes are maintained (Figure 1a). The same level of
funding optimized to minimize the cumulative number of new
infections but in a non-time-varying manner is estimated to
avert 5.1% (4.6% to 5.6%) of these projected new infections
(Figure 1b and Figure 2). VMMC and ART programmes are
prioritized in this allocation, with funding to PMTCT and HTC
remaining at roughly current levels. Allowing the allocation of
funds to optimally vary over time further increases the
number of infections averted to 6.2% (5.5% to 6.6%) (Figure
1c and Figure 2). In this time-varying optimal allocation,
VMMC and ART programmes are initially prioritized, before
FSW programmes are scaled up from an initially low level as
the VMMC programme is scaled down (since fewer new
circumcisions are required to sustain coverage). As with the
time-constant optimization, allocations to PMTCT and HTC
programmes remain at roughly current levels. Details of these
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spending allocations and their associated uncertainties are
provided in the Supplementary file.
Constraining programme scale up or down by 30% per year
and ensuring ART and PMTCT spending cannot reduce past
2014 levels, the estimated number of new infections averted
when allocations are optimally allocated over time is reduced
to 3.3% (3.1% to 3.5%) (compared with the baseline of
maintaining 2014 spending) (Figure 1d and 2). The rapid
initial scale-up of VMMC cannot occur under such constraints
(Figure 3), and as such, the programme is not prioritized in
the optimal allocation. This negatively influences the pro-
jected number of new infections, highlighting the diminishing
Figure 1. Direct programme spending in Zambia between 2014 and 2025 under different scenarios. The 2014 spending allocation is
considered as baseline for the purpose of our scenario comparisons. The plots show optimal redistribution of funds between 2015 and 2025
using (a) no optimization (i.e. maintaining 2014 spending); (b) optimized programme spending that is constant over time; (c) time-varying
optimization of programme allocations, with no constraints; (d) time-varying optimization of programme allocations, considering
implementation constraints (scale-up/down of programmes capped at 30% per year), and ethical constraints (where ART and PMTCT
cannot decrease past 2014 levels); and (e) time-varying optimization of total 2015 to 2025 spending and programme allocations, also
considering the same constraints.
Figure 2. The percentage of infections averted between 2015 and 2025 for each of the scenarios shown in Figure 1 compared with a
baseline of maintaining 2014 spending. The uncertainty bars were determined by repeating the optimization process 40 times using an
ensemble of 40 projections within the uncertainty bounds of the model calibration with an ensemble of 40 cost-outcome curves within their
respective uncertainty bounds (see the Supplementary file for figures illustrating the uncertainty in model calibration and the cost-outcome
curves).
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returns of optimal allocative efficiency when increasingly
restrictive constraints are applied. Supplementary Figure 7
shows a finer granularity of implementation constraints as
well as the improvement in outcomes with varying levels of
funding restrictions. This figure also illustrates the additional
gains from optimal time-varying allocations over optimal
constant solutions, particularly as constraints are introduced.
By allowing the annual budget to be optimally determined
between 2015 and 2025 whilst fixing the total funding to be
equal to constant spending at 2014 levels, we estimate that
7.6% (7.3% to 7.8%) of new infections can be averted whilst
also adhering to the realistic implementation and ethical
constraints. In this optimal allocation of funds, total spending
is initially increased to allow for the rapid scale-up of the
VMMC programme (within the bounds of the implementation
constraint), whilst general adult and youth programmes are
gradually scaled down. Following an initial increase, the total
programme spending is scaled back to comply with the overall
2015 to 2015 funding restriction, which is achieved by scaling
down HTC and, more noticeably, VMMC programmes after
2020.
Resource allocations over a period of five years differ
according to whether associated epidemiological impacts are
assessed after 5-, 10- or 20-year time horizons. For shorter
time horizons, the impact of VMMC on HIV outcomes is not
realized, and therefore, this programme is prioritized to a
lesser degree; instead, there is greater priority for primary
prevention for the general population, which has a more
immediate effect (Figure 4). However, the allocations remain
remarkably similar once the time horizon for impact is
10 or more years (Figure 4). This suggests that considering
a 10-year time horizon for programme funding may be
sufficient to capture most long-term effects.
Our findings suggest that by considering the varying cost-
effectiveness of HIV programmes over time and allocating
funds accordingly, reductions in the number of cumulative new
infections can be achieved when using data from the general-
ized epidemic setting of Zambia. We note, however, that the
Zambian HIV response is to some degree already allocatively
efficient, and therefore, the overall gain of optimizing alloca-
tions of funding is modest. The epidemiological gains were
most pronounced when the total programme spending was
optimally determined rather than held constant over the
optimization period, highlighting the potential impact of
bringing investments in treatment and prevention pro-
grammes forward. Significantly, the epidemiological gains
made under the scenario of optimal total programme spending
were achieved whilst considering realistic implementation and
ethical constraints. In the optimal constant programme
spending scenario, these constraints were not considered,
and the programme allocations were assumed to be able to
scale up instantly. In general, our optimization results here
favour large-scale spending on treatment (supported by
testing), PMTCT and the front-loaded investment of VMMC
programmes.The favoured initial investment of VMMC is likely
due to this being a one-time procedure which maintains
efficacy in individuals for life, and likely has an additional
indirect effect at population level [23].This finding is consistent
with empirical programme evaluations and other modelling
studies [2426].
Our results indicate that fewer health gains occur with
increased constraints on annual changes in programme
Figure 3. Annual spending on VMMC programmes and the associated change in prevalence of circumcised men. In both optimized scenarios
(green and blue curves), implementation constraints (where programme scale-up/down is restricted to a maximum of 30% per year) and
ethical constraints (where ART and PMTCT funding cannot be decreased) are applied. In the scenario represented by the green curve, total
annual spending is fixed at 2014 levels. In this case, a large initial scale-up of the VMMC programme is not attainable because of the limited
availability of unreserved funding and restrictions on programme scale-up/down. Thus, the optimal solution does not prioritize this
programme. In the scenario represented by the blue curve, total annual spending is optimally determined such that total spending across the
2015 to 2025 period is the same as in all other scenarios. In this case, total annual spending is initially increased to allow for the initial rapid
scale-up of the VMMC programme. Although VMMC spending is later rapidly scaled down, the proportion of circumcised men in this scenario
remains considerably higher than in other scenarios.
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spending (Figure 2; Supplementary Figure 7). We found
quickly diminishing returns in the projected epidemiological
outcomes from optimal allocations with increasingly tight
implementation constraints compared with unconstrained
allocations. The implementation constraints discussed in this
study were applied to reflect realistic on-the-ground restric-
tions for the scale-up/down of programmes, although in
many settings opportunities may exist to potentially relax
these constraints by boosting service delivery capacity
through health system strengthening, private sector involve-
ment and performance contracts. One such example has
been observed in South Africa, with the implementation of
performance-based contracting for general practitioners for
VMMC operations [27]. Here, we consider only linear forms
of implementation constraints; however, non-linear restric-
tions on the annual scale-up/down of programmes could also
be incorporated into our methodology. The ethical con-
straints applied in the relevant scenarios are likely to be
necessary restrictions for many governments, particularly in
the case of ART. Because of both the population-level
preventative effect of ART [2830] and the ethical implica-
tions of denying treatment to infected individuals, ART may
often be considered an essential programme for which
funding cannot be retracted.
Our findings indicate that the short-term optimal allocation
of programme funding can vary substantially based on
whether associated outcomes are assessed over a short- or
long-term period (Figure 4). These findings are significant
because of the short-term nature of national governance in
many settings, where expendituremay only be controlled over
short time horizons. Although decision-makers and other
stakeholders generally desire to observe greater outcomes in
the shorter term, ultimately the greatest impact should be
viewed over longer periods. Indeed, programmes such as
infant male circumcision (not considered in this case study)
would require particularly long time horizons to assess the
epidemiological impacts of investments. Interestingly, our
analyses revealed that the optimal allocations when assessing
outcomes over 10- and 20-year periods are essentially
identical. This may be because of the natural course of HIV
infection being around 10 years and that this period covers the
duration in which people may be at their greatest risk.
Significantly, with the resources available for the national
HIV response in Zambia, if the ultimate goal is to minimize
disease burden in the long term, then VMMC should be
prioritized (along with ART), and our results indicate that the
required resources could be made available by gradually
scaling down programmes for the general adult and youth
populations.
Several limitations of this study exist that could be limiting
the epidemiological impact of the optimal allocation solu-
tions. First, our model of the Zambian HIV epidemic considers
all individuals to be in a single geographical location. By
segregating the modelled population groups by location and
redefining the intervention programmes to impact on the
relevant individuals, improvements in epidemiological out-
comes could be achieved by effectively allocating resources
across the geographical regions as well as over time. Second,
our study only considers efficiencies through effective
resource allocation and does not account for potential
technical and implementation efficiency gains. Here, we
assumed that the HIV response expenditure outside the eight
prevention and treatment programmes was for essential
programmes with a fixed cost. In practice, the costs that
are not included in the allocative efficiency optimization
process  which fund enabling environment, research and
other support activities, and sum to around USD$170 million
per year in Zambia  would also need to be reviewed in terms
Figure 4. The optimal redistribution of resources when the period of spending is fixed to five years (from 2015 to 2020), and outcomes are
assessed after (a) five years, (b) 10 years and (c) 20 years. Under each scenario, implementation constraints (scale-up/down of programmes
capped at 30% per year) and ethical constraints (ART and PMTCT cannot decrease past 2014 levels) are observed.
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of efficiency. Another potential limitation of this study, as with
all population-based models, is the granularity with which we
define the population groups; an oversimplification of the
heterogeneity in risk behaviours within a population can
cause inaccuracy in the model findings. Here, we defined the
risk groups for our model of the Zambian HIV epidemic based
on the availability of population-group-specific demographic
and behavioural data and through discussion with partners in
Zambia [15].
We deemed the mathematical function used to define the
programme allocations over time in this analysis to be the
most simplistic function to capture the desired funding
dynamics (constant, front-loaded, rear-loaded or initial scale-
up/down followed by a later scale-down/up). A limitation of
our methodology is that this function may not capture more
complex changes in spending patterns. We also considered a
simpler function that was capable of capturing front-loaded,
rear-loaded and constant allocations over time but not initial
scale-up/down followed by a later scale-down/up. This func-
tion used two parameters to describe funding dynamics for
each programme instead of four parameters used here. Of
these two approaches, the four-parameter approach was able
to consistently locate an allocation that led to a smaller
number of estimated new infections. However, a limitation of
the four-parameter approach is that it requires substantially
more simulation time to derive optimal solutions. A major
factor in this increased simulation time is that the probability
of locating the global minimum (i.e. the true optimal solution)
is decreasedwhen implementing this more complex approach.
Therefore, multiple initial values are randomly chosen, and the
optimization algorithm rerun to boost the likelihood that the
global minimum is located. It is because of this decreasing
likelihood of locating the global minimum with increasingly
complex methodologies, coupled with rapidly diminishing
returns on epidemiological outcomes from these more
complex approaches, that functions with more than four
parameters were not considered here. Further analysis of the
costs and benefits of different functional forms is provided in
the Supplementary file.
Conclusions
It is necessary for governments to do more with what is
available. Optimal allocative efficiency analyses can provide
country stakeholders with quantitative evidence to most
effectively reallocate resources to achieve  to the greatest
extent possible  national goals (or other epidemiological or
economic targets) within an estimated future budget. The
methodology described here enables optimal allocative
efficiency analyses to go a step further by highlighting the
potential gains that can be achieved by targeting the right
programmes to the right people, at the right time.
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